|
13 February
2003
atugen
becomes a Northbank PR client
Berlin
biotech formerly a design client appoints Northbank London as corporate
PRs
London and Manchester
(UK), Munich (Germany). What goes round comes round. atugen, the
German company specialising in the elucidation of disease specific
signal transduction pathways has returned to the fold via an introduction
to the London corporate PR team.
We
are now working with Thomas Christély, CFO & COO,
Klaus Giese, CSO and Zisi Fotev, VP of Business Development,
to raise the profile of the company which they claim applies
the largest
set of mRNA knock-down technologies for discovery and validation
of novel disease targets.
Northbank
will be continuing to position the company as a drug discovery
collaborator as well as a successful
service company.
In support of this, we anticipate that we will soon be helping
with more of their design and advertising work.
back
to news
|